tirzepatide

10 Stories

GLP-1 Drugs Now Considered Essential Medicines

Semaglutide, tirzepatide join WHO list in hope of boosting access in low-income countries

(Newser) - For the first time, the World Health Organization has named popular GLP-1 weight loss drugs as essential medicines, a move set to reshape access to the treatments in countries with limited healthcare resources. The move means semaglutide, the active ingredient in Novo Nordisk's Ozempic, and tirzepatide, the active...

Think Weight-Loss Meds Beat Surgery? Maybe Reconsider

Bariatric surgery still outperforms injections for long-term weight loss, researchers find

(Newser) - A new study suggests that popular weight-loss injections like Wegovy and Mounjaro don't deliver the same dramatic results in everyday use as they do in clinical trials. The drugs, which contain semaglutide and tirzepatide, have been hailed for helping some trial participants lose up to 20% of their...

Mounjaro Beats Ozempic in Head-to-Head Study
Mounjaro Beats Ozempic
in Head-to-Head Study
new study
May 12, 2025 5:04 PM CDT

Mounjaro Beats Ozempic in Head-to-Head Study

Study suggests tirzepatide users lose more weight than semaglutide users

(Newser) - Mounjaro wins bragging rights over Ozempic in a new weight-loss study—though it's one that was funded by the maker of Mounjaro. Researchers found that those taking tirzepatide, marketed as Mounjaro and Zepbound, lost about 20% of their body weight over 72 weeks, according to the study published...

She Wrote About Diets for Years, Kept Gaining Weight
Diet Writer's Advice
Failed to Help Herself
longform
Jan 11, 2025 2:45 PM CST

Diet Writer's Advice Failed to Help Herself

Rebecca Johns explains that after 30 years, the drug Mounjaro is the only thing that's worked

(Newser) - For 30 years, Rebecca Johns tried every diet under the sun and still failed to stop gaining weight. Her story might be familiar to many, but it comes with a twist: Johns was writing about diet tips and fads all the while for various magazines. As she recounts in the...

Eli Lilly to Test Weight-Loss Drugs on Addiction

Company's CEO indicates they'll start testing Zepbound for other forms of treatment in 2025

(Newser) - Earlier this week, Eli Lilly announced it was teaming up with telehealth provider Ro to boost access to Zepbound, one of its weight-loss medications. Now, the pharmaceuticals giant is revealing more plans for its blockbuster drug, noting it wants to start testing Zepbound in 2025 as a treatment not only...

UK's Plan: Give the Unemployed Weight-Loss Drugs

Major study of injection will track 'changes in participants' employment status'

(Newser) - The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed people. The government says a $365 million investment from Eli Lilly will include a "major real-world study" on the effectiveness of tirzepatide, also known as Mounjaro, reports Reuters . The...

Here's How to Spot Fake Ozempic
Here's How to
Spot Fake Ozempic
Jun 21, 2024 4:05 PM CDT

Here's How to Spot Fake Ozempic

WHO warns of counterfeit drugs hitting the US market

(Newser) - The World Health Organization has issued a global alert about counterfeit batches of Ozempic turning up in the US and abroad. Semaglutide, the active ingredient in Ozempic, treats type 2 diabetes by helping control blood sugar levels, but it also makes people feel full with less food, making it a...

It's Forecast to Be Bestselling Drug Ever. Now, a Big Caveat
It's Forecast to Be Bestselling
Drug Ever. Now, a Big Caveat
IN CASE YOU MISSED IT
Dec 16, 2023 6:30 AM CST

It's Forecast to Be Bestselling Drug Ever. Now, a Big Caveat

Study results show patients who went off Zepbound for a year regained half of weight lost

(Newser) - The full results from Eli Lilly's study of its newly approved weight-loss drug Zepbound serve as a splash of cold water in the face of those who believed a few dozen weekly injections would cause pounds to melt off and stay off. The FDA approved Zepbound, with the active...

It's the 'Most Efficacious Drug Ever Approved for Obesity'

FDA approves Zepbound, new version of diabetes drug Mounjaro

(Newser) - A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, US regulators announced Wednesday. NBC News reports the FDA approved Eli Lilly's Zepbound, or tirzepatide, a drug that helped dieters lose 22.5% of their body weight (or 52 pounds) in its phase...

Diabetes Drug Helped Dieters Lose Quarter of Body Weight
This Drug Is Like a 'Medical
Gastric Bypass' for Weight Loss
IN CASE YOU MISSED IT
Oct 21, 2023 12:10 PM CDT

This Drug Is Like a 'Medical Gastric Bypass' for Weight Loss

Experts say Eli Lilly diabetes drug Mounjaro, aka tirzepatide, holds potential for treating obesity

(Newser) - The medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight, or about 60 pounds on average, when combined with intensive diet and exercise, a new study shows. By comparison, a group of people who also dieted...

10 Stories
Most Read on Newser